Search Results - Bangmao Wang
-
1
Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis
Published 2025-12-01Get full textBackground and Objective Janus kinase (JAK) inhibitors (JAKinibs) are effective for inflammatory bowel disease (IBD), but their cardiovascular safety is inconclusive. We aim to assess the cardiovascular risks associated with JAKinibs in IBD patients.Patients and Methods Systematic searches of seven...
Article -
2
Targeting the MDK/c‐Myc complex to overcome temozolomide resistance in glioma
Published 2025-06-01Get full textAbstract Background Temozolomide (TMZ), which is an alkylating agent, is the standard chemotherapeutic drug used for glioma treatment. However, the development of resistance to TMZ limits its efficacy. Thus, identifying novel therapeutic targets is necessary. Methods In this study, the levels of mid...
Article -
3
Systematic Review: Adverse Events of Fecal Microbiota Transplantation.
Published 2016-01-01Get full text<h4>Background</h4>Fecal microbiota transplantation (FMT) is a microbiota-based therapy that shows therapeutic potential in recurrent or refractory Clostridium difficile infections and other intestinal or extra-intestinal disorders. Nonetheless, adverse events (AEs) remain a major challe...
Article -
4
Excessive ultra-processed foods exposure aggravates ulcerative colitis via macrophage ferroptosis
Published 2025-08-01Get full textUlcerative colitis (UC), a chronic inflammatory disease with global prevalence, is increasingly associated with environmental exposure to modern dietary hazards, particularly ultra-processed foods (UPFs) containing oxidized phytosterols. While industrial food processing techniques and repeated oil r...
Article